TY  - JOUR
AU  - Cariolou, Margarita
AU  - Christakoudi, Sofia
AU  - Gunter, Marc J
AU  - Key, Tim
AU  - Pérez-Cornago, Aurora
AU  - Travis, Ruth
AU  - Zamora-Ros, Raul
AU  - Petersen, Kristina Elin T
AU  - Tjønneland, Anne
AU  - Weiderpass, Elisabete
AU  - Kaaks, Rudolf
AU  - Seibold, Petra
AU  - Inan-Eroglu, Elif
AU  - Schulze, Matthias B
AU  - Masala, Giovanna
AU  - Agnoli, Claudia
AU  - Tumino, Rosario
AU  - Di Girolamo, Chiara
AU  - Aizpurua, Amaia
AU  - Rodriguez-Barranco, Miguel
AU  - Santiuste, Carmen
AU  - Guevara, Marcela
AU  - Aune, Dagfinn
AU  - Chan, Doris S M
AU  - Muller, David C
AU  - Tsilidis, Konstantinos K
PY  - 2024
DO  - 10.1093/jncics/pkae070
UR  - https://hdl.handle.net/10668/24323
T2  - JNCI cancer spectrum
AB  - Background: Adiposity has been characterized as a modifiable risk factor for prostate cancer. Its association with outcomes after prostate cancer diagnosis, however, must be better understood, and more evidence is needed to facilitate the development...
PB  - Oxford University Press
KW  - Adiposity
KW  - Association
KW  - Body Mass Index
KW  - Diagnosis
KW  - Disease
KW  - History
KW  - Interleukin-10
KW  - Interleukin-6
KW  - Adiposity
KW  - Prostatic Neoplasms
KW  - Proportional Hazards Models
TI  - Adiposity assessed close to diagnosis and prostate cancer prognosis in the EPIC study.
TY  - research article
VL  - 8
ER  -